What is the Acutaas Chemicals Ltd share price today?

The share price of NSE:ACUTAAS-EQ on 01 Oct 2026 (as of 15:02:57 IST) is ₹3187.

What is the NSE:ACUTAAS-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:ACUTAAS-EQ 52 week high low range shows a high of ₹3740 and a low of ₹1302.

What is the Acutaas Chemicals Ltd market cap?

As on 01 Oct 2026, Acutaas Chemicals Ltd market cap is ₹268468000000.

What is the shareholding pattern of Acutaas Chemicals Ltd Stock?

The shareholding pattern of Acutaas Chemicals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 32.66% Foreign Institutional Investors (FII): 21.61% Domestic Institutional Investors (DII): 5.38% Mutual Funds: 14.17% Retail & Others: 26.18% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Acutaas Chemicals Ltd?

The Price-to-Earnings (PE) ratio of Acutaas Chemicals Ltd is 69.5112, and the Price-to-Book (PB) ratio is 12.6903, as on 01 Oct 2026.

Acutaas Chemicals Share Price

3138.40+16.20 (+0.52%)

+126.32% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.52%

1 Week

-1.82%

1 Month

-0.95%

3 Month

-9.15%

6 Month

+35.15%

YTD

+84.08%

1 Year

+126.32%

5 Year

+372.54%

10 Year

Max

+589.76%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

3120.00

3100.20

3025.00

2255.60

1374.00

High

3216.00

3228.10

3509.90

3700.00

3740.00

About

AMI ORGANICS PVT. LTD.is a manufacturing drug intermediates and catering to both domestics and international market.

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

ACUTAASNSE

LTP

1W Low

1W High

Market cap (₹)

1782.5-18.5 (-1.03%)

1768

1802.90

4,27,562Cr

9326+77 (0.83%)

9113.50

9370.50

2,44,572Cr

4772+4.7 (0.10%)

4702.50

4795

1,80,871Cr

1158.5+12.8 (1.12%)

1128.10

1161.80

1,13,566Cr

1331.2-12.8 (-0.95%)

1321

1337.70

1,07,770Cr

2011+27 (1.36%)

1955.10

2014.50

1,06,117Cr

2490.7-44.3 (-1.75%)

2464.50

2539.30

1,02,433Cr

1205.7-0.5 (-0.04%)

1189

1207.80

1,00,829Cr

1691.6+14.8 (0.88%)

1663.10

1696

96,088Cr

2015.3-15.9 (-0.78%)

1996.30

2029

91,915Cr

3172.7-23.8 (-0.74%)

3100.20

3228.10

25,534Cr

Acutaas Chemicals Share Price

3138.40+16.20 (+0.52%)

+126.32% past 1 Year

Financial overview

Compounded Sales Growth

10 years24%

5 years32%

3 years29%

Last year33%

Compounded Profit Growth

10 years40%

5 years46%

3 years62%

Last year122%

Stock Price CAGR

10 years-

5 years36%

3 years74%

1 year125%

Return on Equity

10 years26%

5 years17%

3 years16%

Last year24%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
24%	32%	29%	33%
40%	46%	62%	122%
-	36%	74%	125%
26%	17%	16%	24%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

ACUTAAS

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,782.5	₹427562 Cr	35.35	12.07	62.82	₹11479 Cr
9,326	₹244572 Cr	83.61	34.04	128.41	₹2568 Cr
4,772	₹180871 Cr	82.93	16.72	97.06	₹2163 Cr
1,158.5	₹113566 Cr	25.16	9.42	62.53	₹5040 Cr
1,331.2	₹107770 Cr	31.97	9.77	57.87	₹3879 Cr
2,011	₹106117 Cr	97.06	6.8	29.25	₹889 Cr
2,490.7	₹102433 Cr	50.15	13.75	71.08	₹1913 Cr
1,205.7	₹100829 Cr	31.29	5.32	63.99	₹4196 Cr
1,691.6	₹96088 Cr	25.88	17.95	96.84	₹3505 Cr
2,015.3	₹91915 Cr	16.62	30.95	154.35	₹5333 Cr
3,172.7	₹25534 Cr	66.11	9.07	51.78	₹356 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
₹330 Cr	₹433 Cr	₹393 Cr	₹306 Cr	₹207 Cr	₹308 Cr	₹275 Cr	₹247 Cr	₹177 Cr	₹225 Cr	₹166 Cr	₹172 Cr	₹142 Cr	₹186 Cr	₹152 Cr	₹147 Cr	₹131 Cr	₹144 Cr	₹141 Cr	₹122 Cr	₹113 Cr	₹93 Cr	₹92 Cr	₹91 Cr
₹2 Cr	₹11 Cr	₹5 Cr	₹10 Cr	₹16 Cr	₹6 Cr	₹2 Cr	₹8 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹2 Cr	₹1 Cr	-₹17 L	₹3 Cr	₹85 L	₹62 L	₹18 L	₹1 Cr	₹16 L	₹1 Cr	₹20,000	₹17 L	₹1 Cr
₹331 Cr	₹444 Cr	₹398 Cr	₹316 Cr	₹223 Cr	₹314 Cr	₹277 Cr	₹255 Cr	₹178 Cr	₹226 Cr	₹170 Cr	₹174 Cr	₹143 Cr	₹186 Cr	₹155 Cr	₹148 Cr	₹132 Cr	₹144 Cr	₹143 Cr	₹122 Cr	₹114 Cr	₹93 Cr	₹92 Cr	₹92 Cr
₹226 Cr	₹259 Cr	₹252 Cr	₹219 Cr	₹164 Cr	₹231 Cr	₹213 Cr	₹205 Cr	₹153 Cr	₹187 Cr	₹144 Cr	₹151 Cr	₹121 Cr	₹149 Cr	₹125 Cr	₹122 Cr	₹111 Cr	₹121 Cr	₹114 Cr	₹97 Cr	₹93 Cr	₹71 Cr	₹71 Cr	₹71 Cr
₹115 Cr	₹195 Cr	₹155 Cr	₹105 Cr	₹67 Cr	₹91 Cr	₹70 Cr	₹57 Cr	₹31 Cr	₹45 Cr	₹30 Cr	₹26 Cr	₹26 Cr	₹41 Cr	₹34 Cr	₹29 Cr	₹24 Cr	₹26 Cr	₹31 Cr	₹28 Cr	₹23 Cr	₹23 Cr	₹22 Cr	₹23 Cr
₹1 Cr	₹1 Cr	₹86 L	₹58 L	₹64 L	₹60 L	₹69 L	₹50 L	₹4 Cr	₹2 Cr	₹3 Cr	₹82 L	₹51 L	₹59 L	₹1 Cr	₹45 L	₹18 L	₹59 L	₹34 L	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹1 Cr
₹104 Cr	₹184 Cr	₹145 Cr	₹96 Cr	₹58 Cr	₹83 Cr	₹63 Cr	₹50 Cr	₹20 Cr	₹37 Cr	₹24 Cr	-₹10 Cr	₹22 Cr	₹37 Cr	₹30 Cr	₹26 Cr	₹20 Cr	₹22 Cr	₹29 Cr	₹23 Cr	₹18 Cr	₹21 Cr	₹19 Cr	₹20 Cr
₹75 Cr	₹134 Cr	₹106 Cr	₹72 Cr	₹44 Cr	₹63 Cr	₹45 Cr	₹38 Cr	₹15 Cr	₹26 Cr	₹18 Cr	-₹17 Cr	₹17 Cr	₹27 Cr	₹22 Cr	₹19 Cr	₹15 Cr	₹21 Cr	₹19 Cr	₹17 Cr	₹14 Cr	₹15 Cr	₹14 Cr	₹15 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
—	—	—	—	—	—	—	—	—	—	—
₹41 Cr	₹41 Cr	₹37 Cr	₹36 Cr	₹36 Cr	₹32 Cr	₹11 Cr	₹11 Cr	₹2 Cr	₹2 Cr	₹2 Cr
₹3 Cr	₹11 L	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1610 Cr	₹1269 Cr	₹635 Cr	₹558 Cr	₹486 Cr	₹135 Cr	₹101 Cr	₹72 Cr	₹56 Cr	₹37 Cr	₹26 Cr
₹1610 Cr	₹1269 Cr	₹635 Cr	₹558 Cr	₹486 Cr	₹135 Cr	₹101 Cr	₹72 Cr	₹56 Cr	₹37 Cr	₹26 Cr
₹1654 Cr	₹1310 Cr	₹674 Cr	₹594 Cr	₹522 Cr	₹167 Cr	₹112 Cr	₹82 Cr	₹58 Cr	₹39 Cr	₹27 Cr
₹57 Cr	₹10 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹114 Cr	₹63 L	₹59 L	₹72 Cr	₹13 Cr	₹12 Cr	₹28 Cr	₹14 Cr	₹14 Cr
₹0	₹0	₹0	₹0	₹0	₹82 L	₹7 Cr	₹11 Cr	₹4 Cr	₹47 L	₹2 Cr
₹29 Cr	₹20 Cr	₹13 Cr	₹9 Cr	₹6 Cr	₹3 Cr	₹3 Cr	₹2 Cr	-₹3 L	-₹4 L	-₹1 Cr
₹9 Cr	₹5 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹5 Cr	₹3 Cr	₹1 Cr	₹68 L	₹44 L	₹4 Cr	₹2 Cr	₹1 Cr	₹98 L	₹63 L	₹37 L
₹42 Cr	₹27 Cr	₹128 Cr	₹10 Cr	₹7 Cr	₹80 Cr	₹25 Cr	₹25 Cr	₹33 Cr	₹15 Cr	₹15 Cr
—	—	—	—	—	—	—	—	—	—	—
₹154 Cr	₹156 Cr	₹135 Cr	₹142 Cr	₹118 Cr	₹85 Cr	₹51 Cr	₹68 Cr	₹48 Cr	₹38 Cr	₹28 Cr
₹12 Cr	₹13 Cr	₹65 Cr	₹7 Cr	₹5 Cr	₹35 Cr	₹9 Cr	₹11 Cr	₹3 Cr	₹5 Cr	₹5 Cr
₹26 Cr	₹8 Cr	₹73 Cr	₹3 Cr	₹0	₹45 Cr	₹34 Cr	₹26 Cr	₹9 Cr	₹9 Cr	₹11 Cr
₹38 Cr	₹25 Cr	₹13 Cr	₹11 Cr	₹6 Cr	₹2 Cr	₹41 L	₹51 L	₹4 Cr	₹2 Cr	₹4 Cr
₹231 Cr	₹202 Cr	₹285 Cr	₹163 Cr	₹129 Cr	₹166 Cr	₹95 Cr	₹106 Cr	₹65 Cr	₹55 Cr	₹49 Cr
₹1984 Cr	₹1549 Cr	₹1096 Cr	₹767 Cr	₹659 Cr	₹413 Cr	₹232 Cr	₹213 Cr	₹155 Cr	₹109 Cr	₹91 Cr
₹17 Cr	₹15 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹19,000	₹7 L	₹8 L	₹0	₹0	₹0
₹26 Cr	₹8 Cr	₹217 Cr	₹4 Cr	₹84 L	₹137 Cr	₹59 Cr	₹54 Cr	₹44 Cr	₹27 Cr	₹30 Cr
—	—	—	—	—	—	—	—	—	—	—
₹862 Cr	₹652 Cr	₹482 Cr	₹298 Cr	₹231 Cr	₹203 Cr	₹98 Cr	₹91 Cr	₹41 Cr	₹35 Cr	₹25 Cr
₹117 Cr	₹81 Cr	₹55 Cr	₹39 Cr	₹27 Cr	₹17 Cr	₹13 Cr	₹12 Cr	₹10 Cr	₹8 Cr	₹6 Cr
₹745 Cr	₹570 Cr	₹427 Cr	₹259 Cr	₹205 Cr	₹186 Cr	₹85 Cr	₹79 Cr	₹32 Cr	₹28 Cr	₹18 Cr
₹332 Cr	₹130 Cr	₹125 Cr	₹26 Cr	₹2 Cr	₹20 L	₹12 Cr	₹2 Cr	₹30 Cr	₹11 Cr	₹4 Cr
₹20 L	₹20 L	₹20 L	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹1 Cr
₹20 L	₹20 L	₹20 L	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹1 Cr
₹24 Cr	₹56 Cr	₹49 Cr	₹17 Cr	₹14 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹76 L	₹54 L	₹48 L
₹91 L	₹88 L	₹1 Cr	₹2 Cr	₹6 Cr	₹1 Cr	₹4 Cr	₹79 L	₹1 Cr	₹1 Cr	₹80 L
₹1103 Cr	₹758 Cr	₹603 Cr	₹310 Cr	₹229 Cr	₹191 Cr	₹105 Cr	₹85 Cr	₹66 Cr	₹42 Cr	₹25 Cr
—	—	—	—	—	—	—	—	—	—	—
₹231 Cr	₹180 Cr	₹157 Cr	₹119 Cr	₹112 Cr	₹60 Cr	₹52 Cr	₹39 Cr	₹27 Cr	₹20 Cr	₹20 Cr
₹363 Cr	₹290 Cr	₹206 Cr	₹230 Cr	₹164 Cr	₹121 Cr	₹56 Cr	₹76 Cr	₹50 Cr	₹36 Cr	₹36 Cr
₹225 Cr	₹249 Cr	₹53 Cr	₹59 Cr	₹100 Cr	₹3 Cr	₹4 Cr	₹49 L	₹1 Cr	₹4 Cr	₹51 L
₹5 Cr	₹3 Cr	₹4 Cr	₹8 Cr	₹11 Cr	₹12 Cr	₹16 L	₹32 L	₹13 L	₹39 L	₹24 L
₹57 Cr	₹69 Cr	₹72 Cr	₹41 Cr	₹43 Cr	₹21 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹9 Cr
₹881 Cr	₹792 Cr	₹493 Cr	₹457 Cr	₹430 Cr	₹216 Cr	₹121 Cr	₹124 Cr	₹87 Cr	₹66 Cr	₹66 Cr
₹650 Cr	₹589 Cr	₹208 Cr	₹294 Cr	₹300 Cr	₹50 Cr	₹26 Cr	₹19 Cr	₹22 Cr	₹12 Cr	₹18 Cr
₹0	₹0	₹0	₹0	₹0	₹6 Cr	₹6 Cr	₹4 Cr	₹2 Cr	₹12 L	₹17 L
₹1984 Cr	₹1549 Cr	₹1096 Cr	₹767 Cr	₹659 Cr	₹413 Cr	₹232 Cr	₹213 Cr	₹155 Cr	₹109 Cr	₹91 Cr
₹202	₹160	₹182	₹163	₹143	₹51	₹101	₹75	₹373	₹259	₹182
₹202	₹80	₹91	₹82	₹143	₹17	₹34	₹25	₹18	₹12	₹9

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
₹483 Cr	₹216 Cr	₹82 Cr	₹112 Cr	₹91 Cr	₹72 Cr	₹35 Cr	₹35 Cr	₹28 Cr	₹19 Cr	₹18 Cr
₹14 Cr	₹19 Cr	₹50 Cr	₹14 Cr	₹14 Cr	₹8 Cr	₹10 Cr	₹7 Cr	₹4 Cr	₹4 Cr	₹3 Cr
-₹93 Cr	-₹70 Cr	₹18 Cr	-₹36 Cr	-₹94 Cr	-₹38 Cr	-₹9 Cr	-₹14 Cr	-₹17 Cr	₹13 Cr	-₹8 Cr
₹404 Cr	₹165 Cr	₹150 Cr	₹90 Cr	₹11 Cr	₹42 Cr	₹35 Cr	₹29 Cr	₹16 Cr	₹35 Cr	₹13 Cr
₹292 Cr	₹118 Cr	₹125 Cr	₹66 Cr	-₹12 Cr	₹28 Cr	₹27 Cr	₹15 Cr	₹8 Cr	₹29 Cr	₹10 Cr
-₹266 Cr	-₹224 Cr	-₹365 Cr	-₹33 Cr	-₹121 Cr	-₹101 Cr	-₹24 Cr	-₹21 Cr	-₹25 Cr	-₹19 Cr	-₹14 Cr
₹4 Cr	₹261 Cr	₹239 Cr	-₹12 Cr	₹140 Cr	₹72 Cr	₹19 L	₹6 Cr	₹15 Cr	-₹7 Cr	₹4 Cr
₹30 Cr	₹156 Cr	-₹86 L	₹20 Cr	₹8 Cr	-₹1 Cr	₹3 Cr	-₹41 L	-₹2 Cr	₹3 Cr	-₹70,000
₹185 Cr	₹30 Cr	₹31 Cr	₹10 Cr	₹3 Cr	₹4 Cr	₹49 L	₹90 L	₹3 Cr	₹32 L	₹33 L
₹0	₹0	₹3 L	₹0	₹0	-₹6,000	₹0	₹0	-₹30,000	-₹10,000	-₹10,000
₹216 Cr	₹185 Cr	₹30 Cr	₹31 Cr	₹10 Cr	₹3 Cr	₹4 Cr	₹49 L	₹90 L	₹3 Cr	₹32 L

Fundamental Ratios

Consolidated

Standalone

No results found

Acutaas Chemicals Share Price

3138.40+16.20 (+0.52%)

+126.32% past 1 Year

Shareholding summary

Promoters

32.66%

FII

21.61%

DII

5.38%

14.17%

Others

26.18%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
32.66%	32.66%	32.66%	32.66%	32.66%	35.96%
21.61%	19.48%	16.67%	16.84%	16.94%	16.48%
5.38%	5.74%	6.59%	6.78%	6.11%	5.29%
14.17%	13.86%	15.11%	15.81%	16.27%	13.02%
26.18%	28.26%	28.97%	27.91%	28.02%	29.25%

Bulk & block deals

Name

Ishares Core Msci Emerging Markets Etf

Kotak Mahindra Mutual Fund.

Kotak Mahindra Mutual Fund

Chetankumar Chhaganlal Vaghasia

Nareshkumar Ramjibhai Patel

Kotak Mahindra Mutual Fund.

Kotak Mahindra Mutual Fund

Chetankumar Chhaganlal Vaghasia

Nareshkumar Ramjibhai Patel

Graviton Research Capital Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
24 Nov 2025	Purchase	98.22 Cr	₹1,852.12	5.30 L	Bulk	0.647713	NSE
19 May 2025	Purchase	150.40 Cr	₹1,115	13.49 L	Bulk	1.647616	NSE
19 May 2025	Purchase	150.40 Cr	₹1,115	13.49 L	Bulk	1.647616	NSE
19 May 2025	Sell	150.40 Cr	₹1,115	13.49 L	Bulk	1.647616	NSE
19 May 2025	Sell	150.40 Cr	₹1,115	13.49 L	Bulk	1.647616	NSE
19 May 2025	Purchase	150.40 Cr	₹1,115	13.49 L	Block	1.647616	NSE
19 May 2025	Purchase	150.40 Cr	₹1,115	13.49 L	Block	1.647616	NSE
19 May 2025	Sell	150.40 Cr	₹1,115	13.49 L	Block	1.647616	NSE
19 May 2025	Sell	150.40 Cr	₹1,115	13.49 L	Block	1.647616	NSE
02 May 2025	Purchase	56.31 Cr	₹1,188.77	4.74 L	Bulk	0.578552	NSE

Insider trading & SAST

Client name

Hemant Mahendabhai Patel

Virendra Nath Mishra

Vijay Gosar

Mehul Mansukhbhai Koladia

Bhavesh Mansukhbhai Kotadiya

Nareshkumar Ramjibhai Patel

Chetankumar Chhaganlal Vaghasia

Nareshkumar Ramjibhai Patel

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
02 Oct 2026	Designated Person	—	0.001221	0	32.72 L	₹3,272	1 K	25 Sep 2026	Pledge Creation	1,000	Insider Trading	—	Equity
02 Jun 2026	Director	Acquisition	0.000145	0.76	3.74 L	₹3,145.59	119	29 May 2026	Market Purchase	6,20,119	Insider Trading	—	Equity Shares
02 Jun 2026	Director	Disposal	0.000145	0.76	3.68 Cr	₹3,09,053	119	29 May 2026	Market Sale	6,20,000	Insider Trading	—	Government Security
02 Jun 2026	Director	Disposal	0.048857	0.76	12.36 Cr	₹3,090.53	40 K	29 May 2026	Market Sale	6,20,000	Insider Trading	—	Equity Shares
10 Mar 2026	Designated Person	Disposal	0.000611	0	10.72 L	₹2,144.26	500	27 Feb 2026	Market Sale	2	Insider Trading	—	Equity Shares
20 Feb 2026	Designated Person	Disposal	0.024429	0.4	4.22 Cr	₹2,110.21	20 K	18 Feb 2026	Market Sale	3,30,000	Insider Trading	—	Equity Shares
30 Dec 2025	Designated Person	Acquisition	0.002565	0	35.12 L	₹1,672.34	2.10 K	29 Dec 2025	Market Purchase	2,100	Insider Trading	—	Equity Shares
22 May 2025	Promoter	Disposal	1.64	17.69	0	—	13.49 L	19 May 2025	Market	1,44,83,327	SAST	29(2)	—
21 May 2025	Promoter	Disposal	1.64	14.97	0	—	13.49 L	19 May 2025	Market	1,22,58,079	SAST	29(2)	—
20 May 2025	Promoter & Director	Disposal	1.64766	17.69	150.40 Cr	₹1,115	13.49 L	19 May 2025	Block Deal	1,44,83,327	Insider Trading	—	Equity Shares

Acutaas Chemicals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Acutaas Chemicals Share Price

Acutaas Chemicals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Acutaas Chemicals Share Price

Acutaas Chemicals Share Price

Oscillators

Moving averages

Acutaas Chemicals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Acutaas Chemicals Share Price

Corporate Actions

Company details

Acutaas Chemicals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Acutaas Chemicals Share Price

News

Acutaas Chemicals commissions Surat pilot plant for high-potency API production

Acutaas Chemicals-linked Indichem opens semiconductor materials plant in South Korea

Acutaas Chemicals secures PLI approval for electrolyte additives investment plan

Incred upgrades Acutaas to Add, raises target on strong Q1FY27 EBITDA

Acutaas Chemicals targets Rs 1,000 crore CDMO revenue with strong pipeline

Acutaas Chemicals ramps battery chemicals output, targets full utilisation in three years

Acutaas Chemicals projects 25 percent FY27 revenue growth with stable margins outlook

Acutaas Chemicals reports higher Q1 EBITDA with stronger margin

Acutaas Chemicals Q1 revenue surges year on year, indicating strong topline growth

Acutaas Chemicals Q1 net profit jumps sharply year-on-year performance update

Acutaas Chemicals informs about corporate presentation

Acutaas Chemicals - Quaterly Results

Acutaas Chemicals MD Confident of 25% Revenue Growth in FY27 vs FY26 Actuals.

Acutaas Chemicals MD Confident of Delivering 25% Revenue Growth in FY27

Acutaas Chemicals Recommends Final Dividend of Rs 2.5 Per Equity Share

Acutaas Chemicals Reports Strong Q4 EBITDA Growth to Rs 181 Crores, Margin at 42.96%.

Acutaas Chemicals Reports Q4 Revenue Growth to Rs 420 Crores from Rs 300 Crores YoY.

Acutaas Chemicals Reports Q4 Standalone Net Profit of Rs 137 Crores, Up from Rs 62.80 Crores YoY.

Acutaas Chemicals reports Profit after tax of 137.07 Crores, in the March 2026 quarter

Acutaas Chemicals board to consider dividend

Acutaas Chemicals Ltd Share Price Today

Acutaas Chemicals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator